157 related articles for article (PubMed ID: 18055714)
1. Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer.
Schmid M; Schneitter A; Hinterberger S; Seeber J; Reinthaller A; Hefler L
Obstet Gynecol; 2007 Dec; 110(6):1231-6. PubMed ID: 18055714
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer.
Six L; Polterauer S; Grimm C; Seebacher V; Tempfer C; Heinze G; Joura E; Reinthaller A; Hefler LA
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):217-21. PubMed ID: 17459567
[TBL] [Abstract][Full Text] [Related]
3. Influence of the time interval between hysteroscopy, dilation and curettage, and hysterectomy on survival in patients with endometrial cancer.
Hefler L; Leipold H; Hinterberger S; Concin N; Klotz R; Reinthaller A
Obstet Gynecol; 2008 Nov; 112(5):1098-101. PubMed ID: 18978111
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of preoperative serum high sensitivity C-reactive protein in patients with endometrial cancer].
Wang LJ; Zhou H; Lu HW; Li J; Lin ZQ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(41):2927-30. PubMed ID: 22333616
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is a prognostic parameter in patients with cervical cancer.
Polterauer S; Grimm C; Tempfer C; Sliutz G; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2007 Oct; 107(1):114-7. PubMed ID: 17617445
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
Polterauer S; Grimm C; Seebacher V; Concin N; Marth C; Tomovski C; Husslein H; Leipold H; Hefler-Frischmuth K; Tempfer C; Reinthaller A; Hefler L
Oncologist; 2009 Oct; 14(10):979-85. PubMed ID: 19776095
[TBL] [Abstract][Full Text] [Related]
7. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
[TBL] [Abstract][Full Text] [Related]
8. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.
Hefler LA; Concin N; Hofstetter G; Marth C; Mustea A; Sehouli J; Zeillinger R; Leipold H; Lass H; Grimm C; Tempfer CB; Reinthaller A
Clin Cancer Res; 2008 Feb; 14(3):710-4. PubMed ID: 18245530
[TBL] [Abstract][Full Text] [Related]
9. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
10. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
[TBL] [Abstract][Full Text] [Related]
11. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
15. Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis.
Polterauer S; Grimm C; Zeillinger R; Heinze G; Tempfer C; Reinthaller A; Hefler L
Anticancer Res; 2011 Jun; 31(6):2259-64. PubMed ID: 21737650
[TBL] [Abstract][Full Text] [Related]
16. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.
Morrison C; Zanagnolo V; Ramirez N; Cohn DE; Kelbick N; Copeland L; Maxwell GL; Fowler JM
J Clin Oncol; 2006 May; 24(15):2376-85. PubMed ID: 16710036
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
19. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
[TBL] [Abstract][Full Text] [Related]
20. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
